Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia-Reference-Cited by-同舟云学术

Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia

Published:2007-05 Issue:4 Volume:137 Page:297-306
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Westermann Jörg,Kopp Joachim,van Lessen Antje,Hecker Ann-Christine,Baskaynak Gökben,le Coutre Philipp,Döhner Konstanze,Döhner Hartmut,Dörken Bernd,Pezzutto Antonio

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2007.06547.x/fullpdf

Reference41 articles.

1. Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells

2. Two distinct HLA-A0201–presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

3. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules

4. Specific human cellular immunity to bcr-abl oncogene-derived peptides

5. Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personal tumor antigens in blood malignancies: genomics-directed identification and targeting;Journal of Clinical Investigation;2020-01-27

2. Preservation of cell-based immunotherapies for clinical trials;Cytotherapy;2019-09

3. Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type;Leukemia;2019-08-27

4. New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia;Frontiers in Oncology;2019-08-06

5. Can Dendritic Cell Vaccination Prevent Leukemia Relapse?;Cancers;2019-06-22